PDGFB and systemic sclerosis: The number of circulating monocytes does not differ between these PAH patient populations (16); however, our results indicate that in macrophages derived from these monocytes, in comparison with control humans, Pdgfb levels were more enhanced in SSc-PAH than in IPAH patients (Figure 6).